Kevin Marsh

Antibodies to voltage-gated calcium channels in children with falciparum malaria.Lang B, Newbold CI, Williams G, Peshu N, Marsh K, Newton CR
J Infect Dis, (2005). 191:117-21

Therapeutic potential of folate uptake inhibition in Plasmodium falciparum.Nzila AM, Kokwaro G, Winstanley PA, Marsh K, Ward SA
Trends Parasitol, (2004). 20:109-12

Malaria and nutritional status in children living on the coast of Kenya.Nyakeriga AM, Troye-Blomberg M, Chemtai AK, Marsh K, Williams TN
Am J Clin Nutr, (2004). 80:1604-10

Mortality among Kenyan children admitted to a rural district hospital on weekends as compared with weekdays.Berkley JA, Brent A, Mwangi I, English M, Maitland K, Marsh K, Peshu N, Newton CR
Pediatrics, (2004). 114:1737-8; author reply 1738

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.Polley SD, Mwangi T, Kocken CH, Thomas AW, Dutta S, Lanar DE, Remarque E, Ross A, Williams TN, Mwambingu G, Lowe B, Conway DJ, Marsh K
Vaccine, (2004). 23:718-28

Clinical features and pathogenesis of severe malaria.Mackintosh CL, Beeson JG, Marsh K
Trends Parasitol, (2004). 20:597-603

Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P, Jensen AT, Lavstsen T, Ofori MF, Marsh K, Hviid L, Theander TG
J Exp Med, (2004). 200:1197-203

Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K
J Infect Dis, (2004). 190:1527-33

Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast.Molyneux CS, Peshu N, Marsh K
Soc Sci Med, (2004). 59:2547-59

Bayesian age-stage modelling of Plasmodium falciparum sequestered parasite loads in severe malaria patients.Smith T, Dietz K, Vounatsou P, Muller I, English M, Marsh K
Parasitology, (2004). 129:289-99

In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.Ommeh S, Nduati E, Mberu E, Kokwaro G, Marsh K, Rosowsky A, Nzila A
Antimicrob Agents Chemother, (2004). 48:3711-4

Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.Staalsoe T, Shulman CE, Dorman EK, Kawuondo K, Marsh K, Hviid L
Infect Immun, (2004). 72:5027-30

Iron deficiency and malaria among children living on the coast of Kenya.Nyakeriga AM, Troye-Blomberg M, Dorfman JR, Alexander ND, Back R, Kortok M, Chemtai AK, Marsh K, Williams TN
J Infect Dis, (2004). 190:439-47

A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants.English M, Mohammed S, Ross A, Ndirangu S, Kokwaro G, Shann F, Marsh K
Arch Dis Child, (2004). 89:665-9

The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes.Kinyanjui SM, Howard T, Williams TN, Bull PC, Newbold CI, Marsh K
J Immunol Methods, (2004). 288:9-18

Pathophysiology of severe malaria in children.Maitland K, Marsh K
Acta Trop, (2004). 90:131-40

Transient cross-reactive immune responses can orchestrate antigenic variation in malaria.Recker M, Nee S, Bull PC, Kinyanjui S, Marsh K, Newbold C, Gupta S
Nature, (2004). 429:555-8

Improving malaria home treatment by training drug retailers in rural Kenya.Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, Ross A, Marsh K
Trop Med Int Health, (2004). 9:451-60

WHO, the Global Fund, and medical malpractice in malaria treatment.White N, Nosten F, Bjorkman A, Marsh K, Snow RW
Lancet, (2004). 363:1160

Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L
Lancet, (2004). 363:283-9